We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep ... Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep and Snore Device, PH Sleep and Snore Device and EVO Sleep and Snore Device, which are used in the treatment and management of mild to moderate obstructive sleep apnea disease. The Company's precision intraoral devices are personalized to each patient's anatomy and treatment plan. Show more
PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial...
In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has...
PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot...
PLEASANTON, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it will...
PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United...
PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is...
PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | -0.111 | -19.1049913941 | 0.581 | 0.61 | 0.47 | 17469 | 0.50829416 | CS |
| 12 | -0.23 | -32.8571428571 | 0.7 | 0.8 | 0.4616 | 69583 | 0.58089878 | CS |
| 26 | -0.1685 | -26.3899765074 | 0.6385 | 1.36 | 0.34505 | 1119106 | 0.96301086 | CS |
| 52 | -4.53 | -90.6 | 5 | 5.1001 | 0.34505 | 537308 | 0.97716521 | CS |
| 156 | -6.6 | -93.3521923621 | 7.07 | 9.41 | 0.34505 | 376995 | 1.01439728 | CS |
| 260 | -6.6 | -93.3521923621 | 7.07 | 9.41 | 0.34505 | 376995 | 1.01439728 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
